|
|
![]() | ![]() | ![]() | ![]() |
This excerpt taken from the CERS 10-Q filed Jul 31, 2008. Schedule 1.1(q): Permitted Investments Borrower holds approximately 12% of the issues shares of BioOne Corporation, a Japanese corporation. Borrower holds 5,000,000 shares of Series AA Preferred Stock of Anza Therapeutics, Inc. (15.50% of issued shares). Borrower has a Certificate of Deposit for $200,000 from Community Bank of the Bay held by county (to secure deposit with respect to radioactive materials). See attached Exhibit A for Borrowers Investment Policy.
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
|
| |||||||